Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology

The acute and long-lasting side effects of modern multimodal tumour therapy significantly impair quality of life and survival of patients afflicted with malignancies. The key components of this therapy include radiotherapy, conventional chemotherapy, immunotherapy and targeted therapies. In addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Rassaf, Tienush, Totzeck, Matthias, Backs, Johannes, Bokemeyer, Carsten, Hallek, Michael, Hilfiker-Kleiner, Denise, Hochhaus, Andreas, Lüftner, Diana, Müller, Oliver J., Neudorf, Ulrich, Pfister, Roman, von Haehling, Stephan, Lehmann, Lorenz H., Bauersachs, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Consensus Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515958/
https://www.ncbi.nlm.nih.gov/pubmed/32405737
http://dx.doi.org/10.1007/s00392-020-01636-7
Descripción
Sumario:The acute and long-lasting side effects of modern multimodal tumour therapy significantly impair quality of life and survival of patients afflicted with malignancies. The key components of this therapy include radiotherapy, conventional chemotherapy, immunotherapy and targeted therapies. In addition to established tumour therapy strategies, up to 30 new therapies are approved each year with only incompletely characterised side effects. This consensus paper discusses the risk factors that contribute to the development of a potentially adverse reaction to tumour therapy and, in addition, defines specific side effect profiles for different treatment groups. The focus is on novel therapeutics and recommendations for the surveillance and treatment of specific patient groups.

Ejemplares similares